Wednesday, June 6, 2012

10 ASC Industry Leaders to Know

From Becker's ASC Review

Written by Rachel Fields | June 02, 2012


Here are 10 profiles of notable leaders in the ambulatory surgery center industry. 

1. Dr. Stephen Hochschuler of the Texas Back Institute. Stephen Hochschuler, MD, is co-founder of the Texas Back Institute in Plano, which began in 1977 in partnership with Ralph Rashbaum, MD. Their joint vision for the institute was to create "an integrated multispecialty spinal clinic that included prevention, conservative care, surgical care, rehabilitation and research and development." Thirty-five years later, the center is heralded as one of the premier organizations for spine healthcare, becoming the first institution in the United States to prescribe outpatient myelography and the first to lead an FDA study of the artificial disc and artificial disc replacement.

2. Barry Tanner, CEO of Physicians Endoscopy. Mr. Tanner joined Physicians Endoscopy in 1999 and co-authored the company's business plan with CFO Karen Sablyak. He currently oversees the company's partnership development activities, as well as strategic direction and services management. He also helps in the day-to-day management and governance of some of Physician Endoscopy's partnered facilities. Before joining PE, Mr. Tanner served as CFO of Navis Radiology Systems, a physician practice management company in Miami. As the co-founder and CFO, he was responsible for developing a business plan. He helped grow the company from zero to over $75 million in revenues during his time as CFO, including the acquisition of seven professional radiology practices and a major diagnostics company.

3. Dr. Kenneth Pettine of Loveland Surgery Center. Kenneth Pettine, MD, is a spine surgeon and the founder of the Spine Institute and Loveland (Colo.) Surgery Center and Rocky Mountain Associates in Orthopedic Medicine. Dr. Pettine is board certified and a member of the American Academy of Orthopedic Surgeons, the North American Spine Society and the Arthroscopy Association of North America. He received his fellowship training at the Institute for Low Back Care in Minneapolis, completed his residency and his master's degree in orthopedic surgery at the Mayo Clinic in Rochester, Minn., and was awarded his MD from the University of Colorado School of Medicine.

4. Michel Kulcyzcki of The Joint Commission. As executive director for The Joint Commission's Ambulatory Care Accreditation Program, Mr. Kulczycki is responsible for overseeing the strategy and business development for the Ambulatory Care Accreditation Program. Prior to joining The Joint Commission in 2002, Mr. Kulczycki served as principal officer at Oak Park, Ill.-based M.Carl Enterprises, a provider of management consultant services to non-profit organizations. He also served as president and CEO of The Alliance for Healthcare Strategy and Marketing in Chicago for two years and as executive director of the Illinois Home Care Council, also in Chicago, for seven years.

5. Brent Ashby, administrator of Audubon Surgery Center. Brent Ashby is the administrator of two surgery centers — Audubon Surgery Center and Audubon ASC at St. Francis, both located in Colorado Springs, Colo. The two Audubon centers contain 15 operating rooms and four procedure rooms between them and perform an estimated 19,000 cases annually. Mr. Ashby has led the surgery centers through several successful initiatives, including a staff profit-sharing program and a boycott of payors who are unwilling to offer reasonable payment rates. He said the physicians in his centers are highly involved and offer their support during difficult administrative decisions.

6. Dr. John Cherf of Vanguard Chicago Center for Orthopedics. John Cherf, MD, an orthopedic surgeon, is the president of the Chicago Institute of Orthopedics, president of OrthoIndex and clinical advisor to Sg2, a healthcare intelligence and information services company. Dr. Cherf, who has more than 20 years of clinical experience in orthopedics and sports medicine, completed his medical education at Northwestern University in Chicago, where he also obtained a Masters in Public Health and Masters in Business Administration. He also completed his internship and residency at Northwestern and then completed a fellowship in sports medicine and knee surgery at The Orthopedic Specialty Hospital/Sports Medicine West in Salt Lake City. 

7. Dr. Joseph Banno, founder of Peroria Day Surgery Center. Joseph Banno, MD, founder of the successful Peoria (Ill.) Day Surgery Center and past ASC chairman, is committed to providing quality healthcare all over the world. He helped pioneer the development of the world's first mobile ASC, a self-contained surgery unit that allows physicians to provide medical and surgical treatment in remote areas of the world. The unit can provide "rural outreach, hospital renovation replacement facility, international health care delivery, mobile intensive care, mobile dialysis" and a variety of other services, Dr. Banno said in an interview with Peoria Magazine.

8. Luke Lambert, CEO of ASCOA. Luke Lambert became CFO of Ambulatory Surgery Centers of America in 1997 and was promoted to CEO of the company five years later. He previously held positions at Smith Barney, Booz, Allen & Hamilton and Ernst & Young. His background includes experience in finance, strategy and operations and he has worked in venture exploration and reengineering business processes. Mr. Lambert was one of the founding members of ASCOA, an ASC management and development company that has started or turned around more than 60 projects in the United States. Within ASCOA’s management model, surgeons maintain the majority ownership of the center while the company holds a minority share in each center it turns around or develops.

9. Joe Zasa, co-founder of ASD Management. As the co-founder and managing partner of ASD Management, Joe Zasa focuses on turning around existing surgery centers and helping physicians and hospitals develop new ASCs. An expert in surgery center profitability, Mr. Zasa is keenly aware of some of the ways ASCs fail: by failing to look at case costs, letting supply expenses run out of control and depending on poor payor contracts. Prior to founding ASD Management, formerly Woodrum ASD, Mr. Zasa served as corporate counsel for Premier Ambulatory Systems, where he was responsible for acquisitions and physician development. He also served as regional director of surgery operations for ProSurg, a division of American Ophthalmic.

10. Alfred McNair, MD, founder of Digestive Health Center. Alfred McNair, MD, a gastroenterologist, founded the Digestive Health Center in 1980 on the Mississippi Gulf Coast, where he has been practicing ever since. He sees patients at four different offices in the area and performs colonoscopies, esophagogastrodeudenoscopies and Enterynx. He also has a special focus on liver disease and hepatitis illness. Dr. McNair earned his medical degree at Columbia University College of Physicians and Surgeons in New York City and completed his residency at New York Presbyterian Hospital. His additional training includes a fellowship at Stanford University in Palo Alto, Calif.

Thursday, April 19, 2012

Spine Leader to Know: Dr. Kenneth Pettine of The Spine Institute

Written by  Bob Spoerl | April 17, 2012 | Becker's Spine Review


Kenneth Pettine, MD, is co-founder of Rocky Mountain Associates in Orthopedic Medicine and The Spine Institute in Loveland, Colo. In addition, he co-invented and co-designed the Maverick Artificial Disk as well as the Prestige Cervical Artificial Disc.
Throughout his career, Dr. Pettine has focused on innovation and was among the first spine surgeons to perform a minimally invasive lumbar disc procedure using the Mesoblast Limited technology. The procedure was performed in a Phase 2 clinical trial of the adult Mesenchymal Precursor Cell product for treating patients with low back pain and degenerative disc disease.

He performs outpatient spine surgery in a surgery center and has predicted that over the next several years, 50 percent of spine procedures could move into the outpatient setting. He also provides cash pay for spine surgery at his center.

"We were noticing many patients were considering going to Germany or India where they could pay cash for an ADR," Dr. Pettine says. "We felt we could offer these patients a cash price similar to what they would pay overseas but allow them to have their surgery close to home by a surgeon they know and trust. Follow up is easier and more efficacious."

Dr. Pettine's background is in spinal surgery, research and rehabilitation. His spine fellowship was at the Institute for Low Back Care in Minneapolis, and he complete residency and a master's degree in orthopedic surgery at the Mayo Clinic in Rochester, Minn. He earned a medical degree from the University of Colorado School of Medicine.

Dr. Pettine holds 14 awards from medical school and residency, has been published 22 times and presented at 45 events and conferences around the world. He recently founded the Society for Ambulatory Spine Surgery, which he launched last November with Access MediQuip. He is a member of the American Academy of Orthopaedic Surgeons, North American Spine Society and Arthroscopy Association of North America.

Friday, March 30, 2012

ASC Industry Leader to Know: Dr. Kenneth Pettine of Loveland Surgery Center

Written by Taryn Tawoda | March 29, 2012 | Becker's ASC Review

Kenneth Pettine, MD, is a spine surgeon and the founder of the Spine Institute and Loveland (Colo.) Surgery Center and Rocky Mountain Associates in Orthopedic Medicine.

When considering surgery center trends for 2012, Dr. Pettine told Becker’s ASC Review, "I think there's going to be a very renewed interest in ASCs. It is profitable to do spine surgery at an ASC for both the spine surgeon and other owners, and implant costs can be a source of additional passive income. Include 12-minute turnaround times and overall efficiency, patient satisfaction and this situation is too good for a spine surgeon not to desire. I have no intention of changing my ownership structure. In fact, I just want to own more."

Dr. Pettine is board certified and a member of the American Academy of Orthopedic Surgeons, the North American Spine Society and the Arthroscopy Association of North America. He received his fellowship training at the Institute for Low Back Care in Minneapolis, completed his residency and his master's degree in orthopedic surgery at the Mayo Clinic in Rochester, Minn., and was awarded his MD from the University of Colorado School of Medicine.

Dr. Pettine previously served as a staff orthopedic surgeon and chief of the sports medicine clinic at Eisenhower Army Medical Center in Fort Gordon, Ga.; associate clinical professor at the Medical College of Georgia; and visiting consultant at the Veteran's Administration Hospital in Augusta, Ga.

Wednesday, March 28, 2012

Positive Signs for Gene Therapy in Slowing the Course of Disc Degeneration

Spinal News International - Issue 22, March 2012 -- view as PDF

A new study, which was presented at the annual meeting of the North American Spine Society (NASS; 2–5 November 2011, Chicago, USA) and subsequently published online in The Spine Journal, has found that gene therapy has the potential to delay disc degeneration.

Lead author Steven Leckie, Department of Orthopedic Surgery, University of Pittsburgh Medical Center, Pennsylvania, USA, and co-investigators reviewed the use of the adeno-associated virus sero-type 2 (AAV2) vector carrying genes for either bone morphogenetic protein 2 (BMP2) or tissue inhibitor of metalloproteinase 1 (TIMP1) to manage degenerative disc disease in New Zealand white rabbits. Explaining the purpose of the study, Leckie, who presented the data at NASS, said: “BMP2 is known to induce proteoglycan production in the intervertebral disc and TIMP1 is anti-anabolic in that it prevents the breakdown of proteoglycan. The problem with growth factors is that they are transient, so the philosophy of gene therapy is that we might be able to induce a sustained response from the host.” He added that, in their study, which won the 2011 outstanding Paper: Basic Science award at NASS, they used AAV2 because it has been shown to be safer than other vectors used in previous studies.

The 34 skeletally mature rabbits used in the study were divided into five groups: non-surgical (negative controls; six), sham procedure (negative controls; four), puncture surgery (underwent puncture surgery but did not receive any subsequent therapy, positive controls; eight), puncture surgery followed by treatment with AAV2-BMP2 (eight), and puncture surgery followed by treatment with AAV2- TIMP1 (eight). Puncture surgery was performed with a 16-gauge needle, which has been reliably shown to induce degeneration, in L2-L3, L3-L4, and L4-L5 discs. Leckie said: “The outcomes that we measured included MRI, histology, biomechanics, and biochemistry.”

After 12 weeks, rabbits in the non-surgical and the sham procedure groups did not show any evidence of disc degeneration on MRI but all rabbits in the puncture surgery group did have evidence of disc degeneration (on MRI, images of nucleus pulpous in the affected area darkened and decreased over the 12 weeks of the study). About the treatment groups, Leckie said: “Although they did have some degree of
disc degeneration, they appeared to have less degeneration than the puncture group.” In The Spine Journal paper, Leckie et al reported that the nucleus pulpous of the treated groups “retained their size and did not darken as much as the punctured discs.”

Leckie said that he and his fellow investigators also collected serum biomarkers for C-telopeptide II, which he explained is the breakdown product of C-terminus of collagen II and could be measured in the serum. He added: “At 12 weeks, the control rabbits had a slight increase [the rabbits in the non-surgical group], the
puncture rabbits had significantly higher serum values, and the treatment groups had values that fell well below those of the puncture group.”

As well as the MRI data and the biomarker data, there was also histological data. Leckie said: “The discs of the control and sham rabbits appeared to be normal. The punctured discs appeared relatively acellular and more fibrotic, and the discs that were treated with AAV2-BMP2 or AAV2-TIMP1 gene therapy had a relative maintenance of cellularity and relative preservation of their architecture.”

Leckie concluded by saying: “We have MRI evidence, serum biomarker evidence, biomechanics evidence, and histology evidence that gene therapy treatment with AAV2-BMP2 or AAV2-TIMP1 might help slow the course of disc degeneration in a rabbit model.”




For Back, Neck Pain, Artificial Disc Replacement Has Cost, Outcome Advantages Over Fusion Surgery

ScienceDaily (Mar. 22, 2011) —

When physical therapy and drugs fail to relieve back or neck pain, patients often turn to spinal fusion surgery as a last resort, but two new studies show that in certain situations, especially when several discs are involved, artificial disc replacement may give better long-term results at lower cost.

Hospital costs for artificial disc replacement were 49 percent lower, and four years out from surgery, artificial disc patients were four times less likely to need additional surgery than those who had fusion operations, according to two recently published studies.

"Back pain is the fifth leading cause of hospital admission and the third most common reason for surgery," said orthopaedic surgeon Rick B. Delamarter, M.D., co-director of the Cedars-Sinai Spine Center. "Estimates vary and are probably understated, but health care expenditures for back pain top $91 billion a year, not including indirect and societal costs such as time lost from work and worker's compensation.It is crucial that we develop surgical procedures that are cost effective without sacrificing high-quality results."

Delamarter is a lead author of the two studies, which were published recently in the SAS Journal of the International Society for the Advancement of Spine Surgery and the Society for Minimally Invasive Spine Surgery.

Both studies compared disc replacement surgery with the more common fusion operation to treat degenerative disc disease -- deterioration caused by aging and wear and tear. One study looked at 209 patients with damaged neck discs who received either minimally invasive disc replacement or the more complex spinal fusion surgery. These patients were followed at regular intervals for four years. A separate group of 136 who received an artificial disc two years after the first group also were part of the study. All patients were assessed on their satisfaction with the results of the procedure. The other study focused on 53 patients suffering from three-level, lower back disc disease and looked at cost comparisons for length of hospital stay, resources used and other factors

Discs act as cushions between the bones (vertebrae) of the spine. When healthy, the discs have enough "give" to allow the back to be flexible but are firm enough to provide stability. With age or injury, they lose their pliability and density. Nerves may become pinched between the bones, causing pain not just in the spine but in other parts of the body.

Fusion surgery seeks to relieve symptoms of the degenerative disease by removing the damaged disc and replacing it with bone. Studies show this procedure often can be effective but there can be drawbacks: in some cases, fused spinal sections can lose flexibility, impeding normal movement and stressing adjacent discs, often leading later to more fusion surgery. Artificial disc replacement, which has been performed in the United States since 2000, tends to cause less tissue injury than fusion surgery, and the discs are designed to maintain natural spine movement and reduce need for follow-up surgery.

In their study of patients suffering neck (cervical) disc disease, Delamarter and his colleagues found both disc replacement and fusion surgery acceptable options providing good long-term outcomes. But four years out from surgery, fusion patients were four times more likely to need more surgery. Half of these secondary operations were needed to treat new disc problems occurring adjacent to fused sections.

Patients in the study had imaging scans to measure before-and-after flexibility and range of motion; were evaluated for physical and neurological improvement; and completed self-assessment questionnaires on neck disability, neck and arm pain intensity. Improvements were seen in all categories, regardless of the surgical procedure, but results tended to be at least slightly better in patients with disc replacements.

An important area, according to Delamarter, was patient satisfaction with the procedure. Four years after surgery, nearly 88 percent of disc replacement patients reported that they were very to completely satisfied, compared with 76 percent of fusion patients. When asked if they would undergo the same surgery again, 89 percent of disc replacement patients and 81 percent of fusion patients said yes.

"While the results of this 13-center study are preliminary, it appears that artificial disc replacement surgery compares favorably as an effective procedure, is preferred by patients and slows the rate of adjacent-level disease," Delamarter said.

Spinal fusion has been recognized as one of the more expensive surgical procedures. The second study looked at costs and is believed to be the first to compare those of three-level disc replacement with three-level fusion. It evaluated itemized billing records of 53 patients undergoing surgery for three consecutive discs of the low back (lumbar spine) at St. John's Health Center in Santa Monica, Calif., where Delamarter practiced before joining Cedars-Sinai.

Total hospital costs for patients undergoing disc replacement surgery averaged 49 percent lower than those for fusion patients.

The number of fusions for low back pain is rising rapidly, but Delamarter urges hospitals, insurers and surgeons to consider alternatives, including total disc replacement.

"After safety and effectiveness of a procedure have been documented, cost is an important consideration," he said. "Artificial disc replacement technology appears to offer a promising, cost-saving alternative to fusion, especially for patients with disease at three levels."

The artificial discs implanted in these studies -- the ProDisc-C and ProDisc-L -- were manufactured by Synthes USA Products. Delamarter and his colleagues have evaluated outcomes and written about the devices since the FDA approved them for research and limited use in the United States. Delamarter is a consultant for Synthes and receives royalties on the ProDisc devices. However, he does not receive royalties on devices used for his patients or any other patients at Cedars-Sinai Medical Center.

read this story online

Monday, March 26, 2012

Becker's ASC Review June Meeting to Gather 700 Industry Leaders to Discuss Orthopedics, Spine, ASC Profitability


Becker's ASC Review will host more than 700 surgery center industry leaders at its annual meeting June 14-16, 2012, at the Westin on Michigan Avenue in Chicago.

Chicago, Illinois (PRWEB) March 25, 2012 

Becker's ASC Review will host more than 700 surgery center industry leaders at its annual meeting June 14-16, 2012, at the Westin on Michigan Avenue in Chicago.
The orthopedic, spine and pain-focused ASC conference brings together surgeons, physician leaders, administrators and ASC business and clinical leaders to discuss how to improve your ASC and its bottom line and how to manage challenging clinical, business and financial issues.
The conference will feature 30 presentations from physician leaders, including: 
  • Everything You Need to Know to Successfully Perform Spine Surgery in an ASC – Ken Pettine, MD, Founder of The Spine Institute and Loveland Surgery Center
  • Evolving Clinical Developments in Interventional Pain Management – Mark Coleman, MD, CEO, National Spine and Pain Centers, LLC
  • Hand Surgery – Key Business Issues for ASCs and Physician-Owned Hospitals – R. Blake Curd, MD, Board Chairman, Surgical Management Professionals
  • Emerging Orthopedic Procedures in ASCs – Business and Clinical Issues – Michael Redler, MD, The OSM Center
Attendees will also have the chance to see a variety of presentations on improving profitability, featuring speakers such as Nancy Boyd of Crane Creek Surgery Center; Luke Lambert, of Ambulatory Surgical Centers of America; Jeff Leland of Blue Chip Surgical Center Partners; Tom Mallon of Regent Surgical Health; Kenny Hancock of Meridian Surgical Partners; Andrew Hayek of Surgical Care Affiliates; Robert Zasa of ASD Management; Charles Peck of Health Inventures; Steve Arnold, MD, of Access MediQuip; and Larry Taylor of Practice Partners.
Keynote speakers for the conference include Lou Holtz, legendary football coach and analyst for ESPN; Tucker Carlson, contributor to FOX News and editor-in-chief of The Daily Caller; and Sam Donaldson, ABC News veteran.
To register, visit: 10th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference10th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference
For information on sponsorship opportunities, contact Jessica Cole at Jessica(at)beckershealthcare(dot)com or call (312) 929-3621.
About Becker’s ASC Review
Becker's ASC Review features general business, legal and clinical guidance for surgery center administrators, physicians and industry leaders. Each of the magazine’s nine annual print issues reaches a qualified audience of more than 25,000 key business leaders and focuses on topics such as joint ventures, development and expansion, regulatory and compliance issues and methods to increase surgery center profitability. Every surgery center in the nation receives Becker’s ASC Review.

Friday, March 23, 2012

The Most Interesting 2.5 Days in the ASC & Spine Business Are Coming — The 10th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference

by the Staff at Becker's ASC Review

This conference includes great spine, orthopedic and pain management physician leaders as speakers. These include speakers such as Charles Gordon, MD, of Texas Spine and Joint Hospital; David Rothbart, MD, of Spine Team Texas; Richard Wohns, MD, of South Sound Neurosurgery; Scott Glaser, MD, of Pain Specialists of Greater Chicago; Kenneth Pettine, MD, of The Spine Institute and Loveland Surgery Center; Brian Cole, MD, of Rush University Medical Center; Laxmaiah Manchikanti, MD, of the American Society for Interventional Pain Management Physicians; John Caruso, MD, of Parkway Surgery Center; John Peloza, MD, of the Center for Spine Care; and James T. Caillouette, MD, of Hoag Orthopaedic Institute will all lead informative sessions about the biggest ideas, challenges and trends in spine, orthopedics and pain management. 

The conference also includes incredible speakers on improving profitability in ASCs such as Nancy Boyd of Crane Creek Surgery Center; Luke Lambert, of Ambulatory Surgical Centers of America; Jeff Leland of Blue Chip Surgical Center Partners; Tom Mallon of Regent Surgical Health; Kenny Hancock of Meridian Surgical Partners; Andrew Hayek of Surgical Care Affiliates; Robert Zasa of ASD Management; Charles Peck of Health Inventures; Steve Arnold, MD, of Access MediQuip; Larry Taylor of Practice Partners in Healthcare; Larry Teuber, MD, of Medical Facilities Crop.; Michael J. Lipomi of Surgical Management Professionals; Gregory DiConciliis of Boston Out-Patient Surgical Suites; John Seitz of Ambulatory Surgical Group; and Edward Hetrick of Facility Development & Management. 

The conference will be held in Chicago, June 14 through June 16, at the Westin Hotel on Michigan Avenue. Key note speakers are legendary football coach Lou Holtz, editor-in-chief of The Daily Caller and Fox News contributor Tucker Carlson and ABC News veteran Sam Donaldson.

To learn more and register, click here.

view the article online here